BioIVT Launches HEPATOMUNE Kit to Facilitate Liver Toxicity and Inflammation Studies for Drug Discovery...
BioIVT, a leading provider of research models and services for drug and diagnostic development, launched...
Samsung Biologics inks development partnership with Dinona for potential COVID-19 treatment
Samsung Biologics (207940.KS) has entered into a partnership agreement with biotech Dinona, further expanding its...
FUJIFILM Diosynth Biotechnologies Stands Ready to Manufacture Lilly COVID-19 Antibody for Low- and Middle-Income...
FUJIFILM Diosynth Biotechnologies, a world leading Contract Development and Manufacturing Organization (CDMO) for biologics, viral...
Mapi Pharma Announces Commissioning of a Vaccine Production Facility to Support the Supply of...
Mapi Pharma Ltd., a fully integrated, late clinical stage biopharmaceutical company, announced that it will...
iBio Enters into Agreement with Safi Biosolutions to Develop Growth Factors and Cytokines Using...
iBio, Inc., a biotech innovator and biologics contract manufacturing organization, announced that it has entered...
Eisai enters joint research pact with four research organizations in Japan for development of...
Eisai Co Ltd announced that it has entered into a joint research agreement with four...
Syngene joins global industry consortium to accelerate collaborative research in COVID-19 testing
Syngene International Limited announced that it has joined a global consortium of 19 organizations from...
Regenerons REGN-COV2 Antibody Cocktail Reduced Viral Levels and Improved Symptoms in Non-Hospitalized COVID-19 Patients
Regeneron Pharmaceuticals, Inc. announced the first data from a descriptive analysis of a seamless Phase...
Major Pharma Companies, Including Novartis And Merck, Build Federated Learning Platform For Drug Discovery
Amgen, Astellas, AstraZeneca, Bayer, Boehringer Ingelheim, GSK, Institut De Recherches Servier, Janssen, Merck, and Novartis...
Alnylam Pharmaceuticals partners with Sharp on packaging RNA interference (RNAi) therapeutics for Europe
Alnylam Pharmaceuticals Inc., the leading RNA interference (RNAi) therapeutics company, and Sharp, part of UDG...